Clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma

Frederic J Kaye1, Alison M Ivey2, Walter E Drane2

  • 1Department of Medicine (FJK) and Clinical Trials Office (AMI), University of Florida Cancer Center; Department of Radiology (WD), Department of Radiation Oncology (WMM), and Department of Pathology, Immunology, and Laboratory Medicine (RWA), University of Florida College of Medicine, Gainesville, FL. fkaye@ufl.edu.

Abstract

No abstract available in PubMed .